()

Peter B Gilbert1, Youyi Fong1, Nima S Hejazi2

  • 1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA, USA.

Vaccine
|March 8, 2024
PubMed
概括

验证免疫保护相关物 (CoP) 对于疫苗开发至关重要. 本研究审查了统计框架,以在第三阶段试验中标准化COP评估,帮助批准疫苗.